Iziguli ezinokuhluleka kwenhliziyo okuqhubekayo zivame ukudinga ukufakelwa kwenhliziyo ngenxa yokulimala okukhulu okutholwe yizinhliziyo zenhliziyo.
Ezigulini ezinjalo zilindele ukufakelwa, amadivaysi anjenge-applation yesobunxele ye-ventricular yokusakazwa okusizayo (amadivaysi okusiza ashisekile, okusiza inhliziyo ukupompa ngegazi ku-oxygen kusuka enhliziyweni emzimbeni. Lawa madivaysi asetshenziswa futhi esikhathini esifushane ukusekela imisebenzi yenhliziyo yeziguli ezenzelwa ukuhlinzwa kwenhliziyo, ziya ngokuya zisetshenziswa njengendlela yesikhathi eside yeziguli ezingakwazi ukuthola ukufakwa kweziguli. Ama-LVADs akhona ane-design enezingxenye ezimbili - ezifakiwe, ezixhunywe ngqo enhliziyweni, futhi zixhunywe kuyo nezintambo zohlelo lwangaphandle oluqukethe isilawuli kanye nokunikezwa kwamandla.
Muva nje, iCorvion ithuthukise i-LVAD efinyelelekayo ngokuphelele, etholwe kusuka ku-American FDA isimo sedivaysi ephumelelayo futhi esevele ibe ngu-2022 izoba ngovivinyo lwasemtholampilo kubantu.
I-ventricle entsha yokufakelwa yenhliziyo efakiwe idla amandla cishe ama-80% ngaphansi kwezinhlelo ezikhona, futhi ingasebenza kusuka kumshuwalense wezempilo wamazwe omhlaba (FDA) wamabhethri angenakufinyeleleka asevunyiwe embonini enokulawulwa yaseMelika. Amabhethri akhiwa kabusha ngesistimu yokushaja engenantambo egqoke, engadingi ukuqondaniswa okunembile noma ukuxhumana nesikhumba. Le ndlela yokushaja ilula kakhulu futhi iphephile esigulini kunezindlela zendabuko zithathwe esikhunjeni. Ngaphezu kwalokho, ekwakhiweni okusha, abathuthukisi bakha ipompo entsha ngokuphelele, babonakaliswa ngokusebenza kahle, ukusebenza kahle kakhulu nokuqina, okubaluleke kakhulu kumadivayisi afakiwe.
Ukuhlolwa kwezilwane kukhombisa imiphumela emihle kakhulu. Abaphenyi bebengabhalisanga amasheya ephampu, noma infourtack emizimbeni yokugcina, ekhombisa ukuthi iphampu ayikhiqizi ama-microns, angaholela emivishweni, enye inkinga enkulu ye-LVAD ekhona.